Topic : Tests/Procedures

Other Topics :

Deep molecular response: what does it mean?

Perhaps the hottest concept in CML research today is that of the “deep molecular response”. So it’s worthwhile to examine how this idea emerged and what it means to people living with CML.
Continue Reading →
Chronic Myelogenous Leukemia DNA

Explaining CML

It’s terrifying when you first hear that you have a form of leukemia called CML (for chronic myelogenous leukemia). There have been remarkable advances in treatment over the past two decades.
Continue Reading →

ASH 2013 – The importance of taking your meds

Starting treatment for CML (or any other chronic illness) introduces something new to your daily routine: taking your medication.
Continue Reading →
Chronic Myelogenous Leukemia test

Tests & procedures: What do they do?

One of the unavoidable consequences of CML is enduring various tests and procedures. Here is a summary of some of the tests.
Continue Reading →
Chronic Myelogenous Leukemia treatments

What do treatments do?

There are three types of approaches to treating the underlying defect in CML. The initial problem is too many white blood cells (WBCs) in the blood. A high WBC count on a blood test is often how CML is first detected.
Continue Reading →

ASH 2013 – Can you stop treatment? The latest results

A few years ago, CML researchers started asking themselves two intriguing questions: If imatinib and other TKIs can suppress CML to such an extent that leukemia is no longer detectable, is this a cure? And would it be possible to stop treatment altogether?
Continue Reading →
CML treatment goal

What are the treatment goals?

When you start taking a TKI to control your CML, there are important milestones along the way that indicate that you’re responding well to the medication.
Continue Reading →

ASH 2013 – Long-term survival: an update

The European Treatment and Outcomes Study (EUTOS) regularly monitors how well people do in clinical trials of CML and has recently analysed data from over two thousand people to look at survival over a six-year period after diagnosis.
Continue Reading →